|
Type of nanoformulations | Method | Encapsulation efficiency (%) | Size (nm) | Beneficial effects | References |
|
Curcumin nanoparticles loaded in Tween 60 | Solvent evaporation nanoprecipitation | 93 | 40-50 | ↓ Endothelial dysfunction | [103] |
Curcumin-loaded liposomes coated with PEG | Film hydration | 80 | 140 | Anti-inflammatory | [54] |
Curcumin-ZnO complex loaded with chitosan | Solvent evaporation followed by ion gelation | Not reported | 43 | ↓ Blood glucose level maintain normal lipid profile ↑ Solubility of curcumin ↑ Antioxidant activity | [72] |
Curcumin-loaded PLGA nanoparticles | Emulsion-diffusion-evaporation | 66 | 237 | Protective effect on inflammatory markers improve lipid metabolisms | [76] |
Curcumin-loaded Pluronic nanomicelles | Nanoprecipitation | 88-91 | 333 | ↑ β-Cell regeneration | [101] |
Curcumin-loaded PLA-PEG nanoparticles | Emulsion-diffusion-evaporation | 98 | 117 | Protective effect on liver inflammation | [73] |
Curcumin-loaded PLGA nanoparticles | Emulsion-diffusion-evaporation | 56 | 282 | Delaying diabetic cataracts | [77] |
Curcumin-loaded nanoparticles coated with chitosan | Ion crosslinking | 77 | 91 | ↑ Healing of diabetic wounds | [107] |
Curcumin nanoparticles within QPAMAM (G3) | Emulsion solvent evaporation | Not reported | 40 | Preventing oxidant mediated diabetic cataract development | [108] |
Curcumin-encapsulated PBLG-PEG-PBLG nanocapsules | Ring-opening polymerization | 32 | 30 | ↓ Diabetic cardiomyopathy | [109] |
|